What is a Cefoxitin Screen on a Sensitivity Report?
A cefoxitin screen on a sensitivity report is a specialized test used to detect methicillin resistance (mecA or mecC-mediated resistance) in Staphylococcus species, serving as a more reliable alternative to oxacillin testing for identifying MRSA (methicillin-resistant Staphylococcus aureus) and methicillin-resistant coagulase-negative staphylococci.
Purpose and Clinical Significance
The cefoxitin screen test is specifically designed to detect the presence of the mecA gene (and less commonly mecC gene) that confers resistance to all beta-lactam antibiotics in staphylococci. This is critical because:
- Cefoxitin is a potent inducer of the mecA regulatory system 1, making it more sensitive than oxacillin for detecting methicillin resistance
- The test identifies organisms that produce altered penicillin-binding protein (PBP2a), which is the mechanism of methicillin resistance 2
- It provides more reliable results than traditional oxacillin testing, particularly for heteroresistant strains that may be missed by oxacillin alone
How to Interpret the Results
Disk Diffusion Method
When you see a cefoxitin screen result on a sensitivity report:
- Zone diameter ≤21 mm for S. aureus = Methicillin-resistant (MRSA) 3
- Zone diameter ≤24 mm for coagulase-negative staphylococci = Methicillin-resistant 4
- Zone diameter ≥22 mm for S. aureus = Methicillin-susceptible 3
Automated Systems
Modern automated susceptibility testing systems (Vitek 2, BD Phoenix) incorporate cefoxitin screen tests with high performance:
- Vitek 2 cefoxitin screen: 100% sensitivity and 98% specificity when used alone 5
- BD Phoenix cefoxitin screen: 84% sensitivity and 100% specificity when used alone, but reaches 100% sensitivity when combined with oxacillin testing 5
Performance Characteristics
The cefoxitin disk diffusion test demonstrates superior performance compared to oxacillin testing:
- Sensitivity: 96.5-100% for detecting mecA-mediated resistance 3, 6, 2
- Specificity: 99.1-100% 3, 6
- No special test conditions required (unlike oxacillin testing which requires specific temperature and salt concentration) 3
Clinical Implications
When a cefoxitin screen is positive (resistant):
- The organism should be considered resistant to ALL beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) except ceftaroline and ceftobiprole
- Treatment should shift to vancomycin, daptomycin, linezolid, or other non-beta-lactam agents
- Infection control measures for MRSA should be implemented
When a cefoxitin screen is negative (susceptible):
- The organism is methicillin-susceptible
- Beta-lactam antibiotics remain appropriate treatment options based on other susceptibility results
Important Caveats
Do not confuse the cefoxitin screen with cefoxitin therapy: The cefoxitin screen is a diagnostic test for detecting methicillin resistance; it does NOT mean cefoxitin should be used for treatment of staphylococcal infections. Cefoxitin itself has limited activity against staphylococci and is primarily used for anaerobic and certain Gram-negative infections 7, 8.
For Enterobacterales: Cefoxitin screening has a completely different purpose—it can be used to screen for AmpC beta-lactamases, though it has poor specificity (25%) and should not be used as a stand-alone test for this purpose 9.